Safety and immunogenicity of an HIV envelope trimer immunogen that elicits CD4 binding site neutralizing antibody precursors (HVTN 300)
Stephen Walsh, William O Hahn, Wilton B. Williams, Ollivier Hyrien et autres
2 citationsmedRxiv
Jessica Andriesen
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
39Publications signalées
1294Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesVaccine Coverage and HesitancyHIV/AIDS Research and InterventionsHIV Research and Treatment
Publications récentes
Profiling of SARS-CoV-2 virus shedding, antibody neutralization, and T-cell receptor repertoires in a large, multi-center cohort of young adults with varied prior exposures
Robin Carroll, James E. Stray, Audrey Pettifor, Tracy Qi Dong et autres
0 citationsUNC Libraries
Profiling of SARS-CoV-2 virus shedding, antibody neutralization, and T-cell receptor repertoires in a large, multi-center cohort of young adults with varied prior exposures
Andrew Fioré-Gartland, Koshlan Mayer-Blackwell, James E. Stray, Moni B. Neradilek et autres
0 citationsFrontiers in Immunology
TCR Data: Profiling of SARS-CoV-2 virus shedding, antibody neutralization and T cell receptor repertoires in a large, multi-center cohort of young adults with varied prior exposures Item
Andrew Fiore-Gartland, Koshlan Mayer-Blackwell, James E. Stray, Moni Neradilek et autres
0 citationsFigshare
TCR Data: Profiling of SARS-CoV-2 virus shedding, antibody neutralization and T cell receptor repertoires in a large, multi-center cohort of young adults with varied prior exposures Item
Andrew Fiore-Gartland, Koshlan Mayer-Blackwell, James E. Stray, Moni Neradilek et autres
0 citationsFigshare
Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIV
Vimla Naicker, Philip Kotze, William Kilembe, Simpson Nuwamanya et autres
0 citationsUNC Libraries
Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIV
Nonhlanhla N. Mkhize, Bo Zhang, Caroline Brackett, Peter Elyanu et autres
1 citationNature Communications
Corrigendum to ‘Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study’. EBioMedicine 2024;108: 105320
Avi Kenny, Janine van Duijn, One Dintwe, Jack Heptinstall et autres
0 citationsEBioMedicine
Evaluating the Test-Negative Design for COVID-19 Vaccine Effectiveness Using Randomized Trial Data
Leah Andrews, M. Elizabeth Halloran, Lars van der Laan, Yunda Huang et autres
6 citationsJAMA Network Open
Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study
Jia Jin Kee, Mubiana Inambao, Essack Mitha, Dishiki Kalonji et autres
0 citationsCarolina Digital Repository (University of North Carolina at Chapel Hill)
Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study
Nigel Garrett, Asa Tapley, Aaron Hudson, Sufia Dadabhai et autres
5 citationsEClinicalMedicine
Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trial
Glenda Gray, Kathryn Mngadi, Ludo Lavreys, Steven Nijs et autres
42 citationsThe Lancet Infectious Diseases
BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.